Hexter Joshua
COO & CBO
Hexter Joshua has filed 7 SEC Form 4 filings (11 transaction rows) across 1 company, with disclosures dating back to 2026. 7 of those filings fall inside the rolling window. Most recent filing: Nov 14, 2026.
On the most recent filing, Hexter Joshua is listed as COO & CBO at ORAMED PHARMACEUTICALS INC. Inside the rolling window, Hexter Joshua reported no open-market purchases and 2 open-market sales totaling $747K in ORMP. The largest disclosed transaction in the window is a sale of 137,000 ORMP shares on Jul 1, 2026, worth $611K.
Companies traded
Other insiders at ORMP
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$747K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Hexter Joshua made?
Hexter Joshua has filed 7 SEC Form 4 filings (11 transaction rows) across 1 company since 2026.
Which companies does Hexter Joshua trade?
Hexter Joshua has filed SEC Form 4 disclosures for 1 company, including ORMP.
When was Hexter Joshua's most recent SEC Form 4 filing?
Hexter Joshua's most recent SEC Form 4 filing on Tracefour is dated Nov 14, 2026.
What is Hexter Joshua's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Hexter Joshua is listed as COO & CBO.
What is Hexter Joshua's total buy and sell value in the current window?
Inside the rolling retention window, Hexter Joshua bought $0 and sold $747K based on SEC Form 4 filings.
What was Hexter Joshua's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 137,000 ORMP shares on 2026-07-01, worth $611K, per SEC Form 4 filings.